Biofrontera INC. (BFRIW) — 8-K Filings

All 8-K filings from Biofrontera INC.. Browse 35 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (35)

8-K Filing — Nov 13, 2025
8-K Filing — Nov 10, 2025
Biofrontera Inc. Files 8-K with Key Agreements and Acquisitions — Nov 7, 2025 Risk: medium
On November 6, 2025, Biofrontera Inc. filed an 8-K report detailing several key events. The company entered into a material definitive agreement and completed a
Biofrontera Inc. Completes Acquisition, Reports Equity Sales — Oct 24, 2025 Risk: medium
On October 20, 2025, Biofrontera Inc. reported the completion of an acquisition. The company also announced unregistered sales of equity securities and entered
Biofrontera Inc. Files 8-K with Regulatory Disclosures — Oct 23, 2025 Risk: low
Biofrontera Inc. filed an 8-K on October 23, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, incorporated in Dela
Biofrontera Inc. Files 8-K on Shareholder Vote Matters — Sep 19, 2025 Risk: low
Biofrontera Inc. filed an 8-K on September 19, 2025, reporting on matters submitted to a vote of security holders as of September 16, 2025. The filing details t
Biofrontera Inc. Files 8-K: Director, Officer, and Compensation Updates — Aug 11, 2025 Risk: low
On August 11, 2025, Biofrontera Inc. filed an 8-K report detailing changes in its board of directors and officers, along with updates on compensatory arrangemen
Biofrontera Inc. Files 8-K with Key Corporate Updates — Jul 1, 2025 Risk: medium
On June 27, 2025, Biofrontera Inc. filed an 8-K report detailing several significant events. These include entering into a material definitive agreement, unregi
Biofrontera Inc. Files 8-K with Financial Updates — Jun 30, 2025 Risk: low
Biofrontera Inc. filed an 8-K on June 30, 2025, reporting on financial statements and exhibits. The filing pertains to the company's operations as of the same d
Biofrontera Inc. Files 8-K on Shareholder Votes — Jun 18, 2025 Risk: low
Biofrontera Inc. filed an 8-K on June 18, 2025, reporting on matters submitted to a vote of security holders as of June 12, 2025. The filing details the company
Biofrontera Inc. Files 8-K Report — Jun 11, 2025 Risk: low
On June 11, 2025, Biofrontera Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific material
Biofrontera Inc. Files 8-K Report — Jun 3, 2025 Risk: low
On June 3, 2025, Biofrontera Inc. filed an 8-K report detailing other events and financial statements. The filing indicates the company's principal executive of
Biofrontera Inc. Faces Delisting Concerns — May 23, 2025 Risk: high
Biofrontera Inc. filed an 8-K on May 23, 2025, reporting a notice of delisting or failure to meet continued listing standards as of May 21, 2025. The company, i
Biofrontera Inc. Faces Delisting Concerns — May 14, 2025 Risk: high
Biofrontera Inc. filed an 8-K on May 14, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, with the earliest eve
Biofrontera Inc. Changes Certifying Accountant — Apr 18, 2025 Risk: low
Biofrontera Inc. filed an 8-K on April 18, 2025, reporting a change in its certifying accountant as of April 17, 2025. The filing also includes financial statem
Biofrontera Inc. Files 8-K on Financials — Mar 21, 2025 Risk: low
Biofrontera Inc. filed an 8-K report on March 21, 2025, detailing its results of operations and financial condition. The filing also includes financial statemen
Biofrontera Inc. Faces Delisting Notice, Enters New Agreement — Nov 27, 2024 Risk: high
On November 21, 2024, Biofrontera Inc. entered into a material definitive agreement related to a direct financial obligation. The company also issued a notice o
Biofrontera Inc. Files 8-K Current Report — Nov 22, 2024 Risk: low
Biofrontera Inc. filed an 8-K on November 22, 2024, reporting on its current status. The filing primarily serves as a notification of events and includes financ
Biofrontera Inc. Files 8-K on Financials — Nov 13, 2024 Risk: low
Biofrontera Inc. filed an 8-K report on November 13, 2024, to disclose information regarding its results of operations and financial condition, as well as finan
Biofrontera Inc. Files 8-K with Financials — Oct 31, 2024 Risk: low
Biofrontera Inc. filed an 8-K on October 31, 2024, reporting on its financial statements and exhibits. The filing details its corporate structure, including com
Biofrontera Inc. Files 8-K Report — Oct 7, 2024 Risk: low
On October 7, 2024, Biofrontera Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No speci
Biofrontera Inc. Files 8-K Report — Jun 24, 2024 Risk: low
On June 24, 2024, Biofrontera Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specifi
Biofrontera Inc. Announces Corporate Changes and Shareholder Vote — Jun 14, 2024 Risk: medium
Biofrontera Inc. announced on June 12, 2024, a series of significant corporate actions. These include the departure of certain directors and officers, the elect
Biofrontera Inc. Files 8-K for Other Events — May 22, 2024 Risk: medium
On May 17, 2024, Biofrontera Inc. filed an 8-K report detailing an event that occurred on the same date. The filing pertains to "Other Events" and was submitted
Biofrontera Inc. Files 8-K with Corporate Amendments — Apr 30, 2024 Risk: low
On April 25, 2024, Biofrontera Inc. filed an 8-K report detailing amendments to its Articles of Incorporation and the filing of financial statements and exhibit
Biofrontera Inc. Files 8-K on Shareholder Vote Matters — Apr 25, 2024 Risk: low
Biofrontera Inc. filed an 8-K on April 25, 2024, reporting on matters submitted to a vote of its security holders on April 24, 2024. The filing details the comp
Biofrontera Inc. Files 8-K on Shareholder Nominations — Mar 26, 2024 Risk: low
On March 26, 2024, Biofrontera Inc. filed an 8-K report detailing its shareholder nominations pursuant to Exchange Act Rule 14a-11, alongside other events and f
Biofrontera Inc. Reports Equity Sales, Rights Modifications — Feb 23, 2024 Risk: medium
Biofrontera Inc. filed an 8-K on February 23, 2024, reporting an event on February 19, 2024, related to an entry into a material definitive agreement, unregiste
Biofrontera Inc. Enters Material Definitive Agreement — Feb 20, 2024 Risk: medium
Biofrontera Inc. entered into a Material Definitive Agreement on February 13, 2024, as reported in this 8-K filing. The filing details the company's incorporati
Biofrontera Files 8-K for Undisclosed "Other Event" — Feb 13, 2024 Risk: medium
Biofrontera Inc. filed an 8-K on February 13, 2024, reporting an "Other Event" that occurred on February 9, 2024. The filing, identified by CIK 0001858685, does
Biofrontera Inc. Files Routine 8-K, Updates Corporate Info — Feb 5, 2024
Biofrontera Inc. filed an 8-K on February 5, 2024, to disclose general corporate information, including its incorporation in Delaware and its business address i
Biofrontera Files 8-K on Material Agreement; Details Undisclosed — Feb 2, 2024
Biofrontera Inc. (BFRI) filed an 8-K on February 2, 2024, reporting an "Entry into a Material Definitive Agreement" and "Other Events" that occurred on January
Biofrontera Inc. Receives Nasdaq Delisting Notice for Bid Price Non-Compliance — Jan 25, 2024
Biofrontera Inc. (BFRI) filed an 8-K on January 25, 2024, reporting that on January 19, 2024, it received a notice from Nasdaq indicating the company failed to
Biofrontera Inc. Files 8-K on Financial Condition & Operations — Jan 11, 2024
Biofrontera Inc. filed an 8-K on January 11, 2024, to report on its current financial condition and operations. This filing, under Items 2.02 and 9.01, indicate
Biofrontera Enters Material Definitive Agreement; Details Undisclosed — Jan 3, 2024
Biofrontera Inc. filed an 8-K on January 3, 2024, reporting an "Entry into a Material Definitive Agreement" on December 29, 2023. While the filing indicates a s

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX